Podcasts about bauml

Komm ran Frühling - das denken nicht nur wir, auch die Vögel sind mehr als bereit! Das lassen sie uns auch gerne hören und damit ihr richtig zuhören könnt, helfen euch eure Lieblingsnerds, Fabian und Martin, beim Knacken des "Zwitschercodes". Wie kann ich die kleinen Baumläufer auseinanderhalten? War das gerade eine Sing- oder doch eine Misteldrossel? Außerdem gibt es einen kleinen Rückblick der bisherigen Vogelstimmenepisoden. Also, hört rein! Diese Folge wurde von Neudorff gesponsert: Der Podcast „Einfach natürlich gärtnern“ ist für Menschen mit Garten, die keinen grünen Daumen haben, aber trotzdem gärtnern wollen. Mehr Infos unter: [https://www.neudorff.de/podcast ](https://www.neudorff.de/podcast ) Alle Infos und die Links zu den Vogelnews dieser Episode findet ihr wie immer auf: [NABU.de/vogelpodcast](http://www.NABU.de/vogelpodcast) Abonniert unseren Podcast, empfehlt uns gerne weiter und lasst gerne eine Bewertung da. Schickt eure Fragen, Lob und Kritik an vogelpodcast@NABU.de Wenn ihr keine neue Folge verpassen wollt, aktiviert die Benachrichtigung in eurer Podcast-App.

Die Basler SP-Grossrätin Amina Trevisan will die Geschichte der Saisonniers und Saisonnières aufarbeiten lassen. In der Region Basel gab es nämlich besonders viele solche Arbeitskräfte, welche die Schweiz aus Italien und anderen südeuropäischen Ländern geholt hat. Ausserdem: * Marienkäfer sollen Kirschbäume vor Baumläusen retten * Ausstellung in Basel zeigt Kriegs-Reportagen aus der Ukraine in Comics-Form Weitere Themen: - Kinder versteckt oder zurückgelassen: Saisoniers in Baselstadt

Der Gartenbaumläufer ist ein kleiner Wicht, der eigentlich aussieht wie ein puffiger Federball, winzig, häufig singend und immer unterwegs. Sowohl bei Antonia in Köln in der Stadt, als auch bei Philipp auf dem Land sieht man ihn häufig die Bäume hoch huschen, immer auf der Suche nach kleinen Insekten hinter der Rinde alter Bäume, auf die er angewiesen ist. Daher heißt er wohl Baumläufer, nicht wahr? Was der Gartenbaumläufer mit Hildegard Knef zu tun hat (gar nichts) und was er mit der britischen Band Radiohead zu tun hat (sehr viel), das und vieles mehr erfahrt ihr in dieser Folge! . Wer Bock auf Vogelfutter hat: Mit dem Code „Podcast10“ bekommt ihr drei Mal 10% Rabatt bei Welzhofer-Vogelfutter, das wir Euch wärmstens empfehlen. Jetzt einlösen unter www.welzhofer-shop.de oder www.mein-mühlenshop.de

In this episode of ‘How This is Building Me,' Camidge sits down with Bauml to discuss the transition from academia to industry, reasons for the move, expectations for the future, and more.

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. 

whats up everybody!! welcome to The Bottle Rocket Company, where we learn things and talk to the people who helped make my debut album Sunflower!! this week we have Joey Brodnax and Drew Bauml on the pod to talk about how they got their start in directing and making visual art and how we all came together in good ole nashville tennessee. I love these fellas so much and hope you do too!!! joey is @joeybrodnax drew is @drew_drew_a_picture

PRAETORIUS: Laudate Dominum (2.22). Salve Rex noster (versión adaptada a la liturgia protestante del “Salve Regina” a 8 voces) (9.05). Jubilate Deo a 7 voces (6.39). D. Visse (contraten.), Capella de la Torre. Dir.: K. Bauml. SWEELINCK: De profundis clamavi (4.08). Ecce prandium meum paravi (4.08). Gaude et laetare, Jerusalem (2.11). Chantez à Dieu nouveau cantique (5.59). S. Stubbs (laúd), J. Rubin (laúd), B. Winsemius (órg.), Coro de Cámara de Holanda. Dir.: W. Christie. PRAETORIUS: La bourée a 4 (2.10). Ballet des cocqs a 5 (1.35). Courante (2.04). Ensemble Musica Aurea. Escuchar audio

Dr. Josh Bauml, member of the GRACE faculty, discusses emerging molecular targets in non small cell lung cancer for RET fusions.For more information visit www.cancerGRACE.org

Dr. Josh Bauml, member of the GRACE faculty, discusses emerging molecular targets in non small cell lung cancer with a MET mutation. for more information visit www.cancerGRACE.org

The Small Biz Insider podcast is part of a digital series from the Greater Houston Partnership, where we highlight the innovative business owners, entrepreneurs and leaders of the greater Houston area making a big impact in the small business community. On this edition of Small Biz Insider, host Maggie Martin sits down with Lauren Bauml, Campus Director for Flatiron School Houston and Austin, a coding bootcamp with tech's most effective software engineering and data science courses – online and on-campus in Houston and other major U.S. cities.

Dr. Jack West provides a brief summary of key findings & limitations of two new papers just out in JAMA Oncology (Theelen et al & Bauml et al.) that evaluate the potential benefit of preceding immunotherapy with radiation in patients with advanced NSCLC.

Dr. Jack West provides a brief summary of key findings & limitations of two new papers just out in JAMA Oncology (Theelen et al & Bauml et al.) that evaluate the potential benefit of preceding immunotherapy with radiation in patients with advanced NSCLC.

Barfußschuhe, Vietnam, Tyrannei, Baumländer, Downbreak, Fanboykott, Fortnite-Jubel, Blick auf die Tabelle

GRACE is happy to present the 8th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer.  Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016. Drs. Weiss, Bauml and Seiwert discuss the promising early data for the oral inhibitor Buparlisib.

GRACE is happy to present the 9th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer.  Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016. Drs. Weiss, Bauml and Seiwert discuss the topic of whether there are less toxic alternatives to the extreme regimen.

GRACE is happy to present the 9th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer.  Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016. Drs. Weiss, Bauml and Seiwert discuss the topic of whether there are less toxic alternatives to the extreme regimen.

GRACE is happy to present the 8th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer.  Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016. Drs. Weiss, Bauml and Seiwert discuss the promising early data for the oral inhibitor Buparlisib.

GRACE is happy to present the 8th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer.  Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016. Drs. Weiss, Bauml and Seiwert discuss the promising early data for the oral inhibitor Buparlisib.

GRACE is happy to present the 9th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer.  Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016. Drs. Weiss, Bauml and Seiwert discuss the topic of whether there are less toxic alternatives to the extreme regimen.

7th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding ASCO 2016 HN RT-Using Immunotherapy as First-Line Treatment and in Combinations.

7th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding ASCO 2016 HN RT-Using Immunotherapy as First-Line Treatment and in Combinations.

7th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding ASCO 2016 HN RT-Using Immunotherapy as First-Line Treatment and in Combinations.

6th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding keynote 55: Pembrolizumab for heavily pre-treated patients.  

6th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding keynote 55: Pembrolizumab for heavily pre-treated patients.  

6th video in our series ASCO 2016 Head and Neck Roundtable, featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD. Dr. Weiss moderates the discussion regarding keynote 55: Pembrolizumab for heavily pre-treated patients.  

Dr Bauml speaks with ecancertv at ASCO 2016 to discuss the first findings of KEYNOTE 055, a trial for PD-L1/2 blocking pembrolizumab for patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). Pembrolizumab showed promising anti-tumour activity in earlier KEYSTONE 012 results, which are confirmed in this setting with an overall recovery rate of 18% and a stable disease rate of 18%. Dr Bauml discusses the impact of these findings for those whom platinum and cetuximab therapy had failed, the wider aspects of checkpoint inhibitory therapy, and next steps for the trial.

  GRACE is happy to present the 3rd video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer.  Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016. Drs. Weiss, Bauml and Seiwert discuss the using biomarkers in immunotherapy.    

  GRACE is happy to present the 3rd video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer.  Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016. Drs. Weiss, Bauml and Seiwert discuss the using biomarkers in immunotherapy.    

  GRACE is happy to present the 3rd video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer.  Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016. Drs. Weiss, Bauml and Seiwert discuss the using biomarkers in immunotherapy.